(Press-News.org) This press release is available in French.
Montreal, January 24, 2013 – People who take immunosuppressive drugs to treat lupus do not necessarily increase their cancer risk according to new research led by scientists at the Research Institute of the McGill University Health Centre (RI-MUHC). This landmark study, which was published in Annals of the Rheumatic Diseases this month, addresses long-standing fears of a link between lupus medication and cancer.
Systemic lupus erythematosus (SLE), commonly known as lupus, is an autoimmune disease in which the body's immune system attacks healthy tissue such as the skin, joints, kidneys and the brain, leading to inflammation and lesions. The disease affects about 1 in 2000 Canadians, particularly women.
Previous research has suggested that lupus patients have an increased risk of developing cancer, particularly lymphoma. Lymphoma is a type of blood cancer that occurs when cells called lymphocytes, which usually help protect the body from infection and disease, begin growing and multiplying uncontrollably leading to tumor growth.
"Treatment for Lupus consists largely of immunosuppressive medications, which lower the body's immune response," explains Dr. Sasha Bernatsky, first and corresponding author of the study, who is a researcher within the Divisions of Clinical Epidemiology and Rheumatology at the RI-MUHC and at McGill University.
According to Dr. Ann E. Clarke, director of the MUHC lupus clinic and study co-lead, the fear of developing cancer among Lupus patients has been so great that some were reluctant to take their medication and others stopped altogether.
The international study involved 75 lupus patients with lymphoma from different centres around the world and nearly 5,000 cancer-free lupus patients as a control.
Researchers studied most of the drugs commonly used to treat SLE including cyclophosphamide, a drug reserved for severe lupus cases and other chronic inflammatory rheumatic diseases.
The results showed that the risk for lymphoma in lupus patients exposed to cyclophosphamide was less than 0.1% per year. In addition, no clear association was observed between lupus disease activity and lymphoma risk.
"People have been wondering for a long time whether the medications were to blame and the results are reassuring, suggesting that most lymphoma cases in SLE are not triggered by drug exposures," says Dr. Bernatsky.
"This is very good news that cancer risk associated with lupus medication is relatively low," said Louise Bergeron, who has been living with lupus for 12 years.
"It reassures me, especially if I need to take more effective immunosuppressive treatments in the coming years."
Future research will focus on the genetic profiles of lupus patients and what impact that can have on the interaction between medication exposure and lymphoma risk in lupus.
###
Click here to access the study online: http://ard.bmj.com/content/early/2013/01/08/annrheumdis-2012-202099.abstract
Funding
This work was funded by the Canadian Institutes of Health Research (CIHR) and the National Institutes of Health (NIH).
Useful links
Research Institute of the MUHC: muhc.ca/research
McGill University Health Centre (MUHC): muhc.ca
McGill University: mcgill.ca
Media
Julie Robert
Communications – Research
Public Affairs & Strategic Planning
McGill University Health Centre
Phone: 514-934-1934 (ext. 71381)
julie.robert@muhc.mcgill.ca
Research: Lupus drugs carry no significant cancer risk for patients
2013-01-24
ELSE PRESS RELEASES FROM THIS DATE:
Female mice exposed to BPA by mothers show unexpected characteristics
2013-01-24
ANN ARBOR—Female mice exposed to Bisphenol A through their mother's diet during gestation and lactation were found to be hyperactive, exhibit spontaneous activity and had leaner body mass than those not exposed to the chemical, researchers at the University of Michigan School of Public Health have discovered.
BPA is a chemical most commonly found in the lining of food cans and cash register receipts. It once was in many hard plastic bottles, including baby bottles, but many companies have removed it as concerns about exposure have come to light in recent years.
These ...
Abuse during childhood linked to uterine fibroids in African-American women
2013-01-24
(Boston) – According to a new study from the Slone Epidemiology Center (SEC) at Boston University, African-American women who reported sexual or physical abuse before age 11 had a greater risk of uterine fibroids in adulthood compared with women who had no such abuse history. The association was strongest for women who experienced sexual abuse.
The study, which is published online in the American Journal of Obstetrics and Gynecology, was led by Lauren A. Wise, ScD, senior epidemiologist at SEC and associate professor of epidemiology at the Boston University School of ...
Greenland ice cores provide vision of the future
2013-01-24
Ice cores drilled in the Greenland ice sheet, recounting the history of the last great warming period more than 120,000 years ago, are giving scientists their clearest insight to a world that was warmer than today.
In a paper published today in the journal Nature, scientists have used a 2,540 metre long Greenland ice core to reach back to the Eemian period 115-130 thousand years ago and reconstruct the Greenland temperature and ice sheet extent back through the last interglacial. This period is likely to be comparable in several ways to climatic conditions in the future, ...
Personal epigenetic 'signatures' found consistent in prostate cancer patients' metastases
2013-01-24
In a genome-wide analysis of 13 metastatic prostate cancers, scientists at the Johns Hopkins Kimmel Cancer Center found consistent epigenetic "signatures" across all metastatic tumors in each patient. The discovery of the stable, epigenetic "marks" that sit on the nuclear DNA of cancer cells and alter gene expression, defies a prevailing belief that the marks vary so much within each individual's widespread cancers that they have little or no value as targets for therapy or as biomarkers for treatment response and predicting disease severity.
A report of the discovery, ...
New method of producing nanomagnets for information technology
2013-01-24
Jülich, 23 January 2013 – An international team of researchers has found a new method of producing molecular magnets. Their thin layer systems made of cobalt and an organic material could pave the way for more powerful storage media as well as faster and more energy-efficient processors for information processing. The results of this research have been published in the current issue of the renowned journal Nature (DOI: 10.1038/nature11719).
In order to boost the performance of computers and reduce their energy requirements, processors and storage media have become smaller ...
There were more small meat-eating dinosaurs than first thought
2013-01-24
(Edmonton) University of Alberta researchers used fossilized teeth to identify at least 23 species of small meat-eating dinosaurs that roamed western Canada and the United States, 85 to 65 million years ago.
Until now, only seven species of small two-legged meat-eating dinosaurs from the North American west had been identified.
U of A palaeontologist Philip Currie and student Derek Larson examined a massive dataset of fossil teeth that included samples from members of the families to which Velociraptor and Troodon (possibly the brainiest dinosaur) belong.
"Small meat-eating ...
Underwater CO2 shows potential as barrier to Asian carp
2013-01-24
URBANA – As the Asian carp population grows and the threat of the invasive species entering Lake Michigan through one of the Chicago canals is monitored, a University of Illinois researcher believes using two barrier methods is better than one.
Cory Suski experimented with adding carbon dioxide (CO2) into the water as a supplemental tool to work in tandem with the electric fence, which has been used to divert the carp from entering the canal, with the goal of providing a second line of defense.
Suski found that carbon dioxide is quick and effective in repelling fish ...
Novel aptamer boosts T cell-based immune response to therapeutic vaccines
2013-01-24
New Rochelle, NY, January 22, 2013—A small compound called an aptamer that specifically targets and stimulates a human immune cell can greatly increase the effectiveness of an immunotherapeutic drug designed to destroy malignant or virus-infected cells. The development of a novel apatamer that recognizes activated T-lymphocytes and can boost the therapeutic effect of cell-based vaccines is described in an article in Nucleic Acid Therapeutics, a peer-reviewed journal from Mary Ann Liebert, Inc. publishers (http://www.liebertpub.com). The article is available on the Nucleic ...
Microbiologists eavesdrop on the hidden lives of microbes
2013-01-24
(CAMBRIDGE, MA) -- Microbiologists who study wild marine microbes, as opposed to the lab-grown variety, face enormous challenges in getting a clear picture of the daily activities of their subjects. But a team of scientists from MIT and the Monterey Bay Aquarium Research Institute recently figured out how to make the equivalent of a nature film, showing the simultaneous activities of many coexisting species in their native habitat over time.
Instead of making a movie, the scientists used a robotic device that dangled below the surface of the ocean, drifting in the water ...
Scientists identify new strategy to fight deadly infection in cystic fibrosis
2013-01-24
COLUMBUS, Ohio – New research suggests that lowering excessive levels of a protein in immune system cells could be a strategy to clear an infection that is deadly to patients with cystic fibrosis (CF).
Researchers determined that normalizing levels of the protein, called p62, in cells from mice carrying the most common mutation that causes CF will jump-start a natural cellular process that clears away the offending bacteria.
The scientists had previously determined that in cells from mice and humans carrying the CF mutation, the bacteria that cause this infection interfere ...